Notice of Annual General Meeting in Ascelia Pharma AB

April 4, 2025 8:00 AM

Ascelia Pharma (STO:ACE) - The shareholders in Ascelia Pharma AB, Reg. No. 556571-8797, are hereby invited to the annual general meeting (Sw. årsstämma) to be held at the premises of Setterwalls Advokatbyrå at Stortorget 23 in Malmö on Wednesday 7 May 2025 at 2 p.m. CEST.Right to participate and notice of participationShareholders wishing to attend the annual general meeting must:be registered in the company's share register kept by Euroclear...

Read more

Ascelia Pharma Announces Acceptance of Study on Burden of Illness Real-World Data of Orviglance Target Patients for Presentation at the ISPOR 2025 Conference

April 4, 2025 2:00 AM

Ascelia Pharma (STO:ACE) - Ascelia Pharma AB (publ) (ticker:ACE), a biotech focused on improving the life of people living with rare cancer conditions, today announced that the abstract titled ‘Burden of Illness in US Patients with Liver Cancer and Kidney Disease - A Real-World Claims Analysis' has been accepted for presentation at the Professional Society for Health Economics and Outcomes Research (ISPOR) Conference, taking place 13-16 May in...

Read more

American College of Osteopathic Family Physicians Conclave of Fellows Welcomes 2025 Class

April 3, 2025 9:00 PM

The American College of Osteopathic Family Physicians (ACOFP) Conclave of Fellows honored thirteen physicians with the designation of Fellow of the ACOFP and three with the designation of Distinguished Fellow of the ACOFP during its 62nd Annual Convention & Scientific Seminars in Palm Springs, California.The designation of Fellow is bestowed upon candidates who have contributed outstanding national and local service through teaching, authorship,...

Read more

Arthritis Foundation and American College of Rheumatology Denounce the Dismantling of Programs Critical to Arthritis Research and Chronic Disease Prevention

April 3, 2025 7:04 PM

As organizations representing nearly 60 million adults and children living with arthritis in the United States and the rheumatologists and health care professionals who treat them, we are deeply alarmed by this week's dismantling of multiple branches of the Centers for Disease Control and Prevention (CDC) that manage essential research and public health programs critical to the well-being of millions of people living with chronic...

Read more

Onco-Innovations' Inka Health Completes Analytical Work for AstraZeneca Canada, Advancing Pharmaceutical Analytics and Leading to Key Studies at ISPOR 2025

April 3, 2025 6:00 PM

Onco-Innovations Limited (CSE:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce that its wholly owned subsidiary, Inka Health Corp. ("Inka Health"), which the Company acquired on or about February 3, 2025 (please see news release dated February 3, 2025), has now successfully completed analytical work under contract ("AZ Services Agreement") for AstraZeneca Canada ("AstraZeneca"), contributing to...

Read more

enBio Corp Appoints Esteemed Healthcare Executives to Advisory Board to Guide Strategic Growth

April 3, 2025 11:45 AM

enBio Corp, a leader in clinical technology services and medical equipment solutions, is proud to announce the formation of its Advisory Board with the appointment of three nationally recognized healthcare executives: Michael T. Phillips, FACHE, Lloyd Duplechan and Dave Francoeur. Together, these leaders bring unmatched experience in hospital operations, biomedical engineering, regulatory compliance, and strategic transformation.The Advisory...

Read more

Travel Nurses, Inc. Announces Partnership With Souled Outside Exploration Co.

April 3, 2025 11:00 AM

Travel Nurses, Inc. entered a partnership with Souled Outside Exploration Co. The agency is now a title sponsor of a television series called Souled Outside Travel Tales hosted by travel writer Joe Sills and travel nurse Liz Hooper.This new episodic TV series, airing in 2025, will blend travel nursing stories with outdoor exploration across the globe, showcasing inspiring journeys from California to Kathmandu on streaming platforms like Apple TV...

Read more

Leading Austin Plastic Surgeon Dr. Rocco Piazza Selected to Pilot Motiva Implant Technology

April 3, 2025 11:00 AM

The Piazza Center proudly announces that board-certified plastic surgeon Dr. Rocco Piazza has been selected as one of the few elite plastic surgeons in Austin, TX, to pilot Motiva's innovative implant technology. With over 15 years of experience specializing in breast and body procedures, Dr. Piazza continues to set new standards in aesthetic surgery and patient care.Motiva Implants®, known for their advanced safety, softness, and natural look...

Read more

Sunshine Biopharma Inc. Announces Closing of $2.46 Million Registered Direct Offering

April 3, 2025 10:50 AM

Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals, today announced the closing of the previously announced registered direct offering with institutional investors of approximately $2.46 million of shares of Common Stock and pre-funded warrants at a price of $2.07 per share of Common Stock. The entire...

Read more

Exousia Pro Issues Update on Name Change

April 3, 2025 10:30 AM

MARIJUANA INC. (OTC PINK:MAJI), dba Exousia Pro, Inc., a clinical-stage biotech company utilizing exosomes in the treatment of cancer and other diseases, is pleased to announce that the Company has received comments from FINRA regarding the name change.FINRA has requested specific Board minutes and the stamped Articles of Amendment from the State of Florida showing the name change from Marijuana, Inc. to Exousia Pro, Inc.We submitted the...

Read more

Gubra Welcomes New Board Members at 2025 AGM

April 3, 2025 10:30 AM

Gubra (CPH:GUBRA)Following Gubra's Annual General Meeting 2025 taking place earlier today we are pleased to confirm some exciting changes to the Board welcoming new perspectives to support the journey ahead.As recommended by the Nomination Committee, the following members were re-elected to the Board:Jacob JelsingMonika LesslAlexander Thomas Martensen-LarsenAstrid HaugArndt Justus Georg SchotteliusHenriette Dræbye Rosenquist did not stand for...

Read more

The Centrifuge Sessions: Driving Innovation and Investment in Cancer Research

April 3, 2025 9:45 AM

We're focused on driving innovation in virology, oncology and immunology - and that includes investing in world-class science to change the way cancer is treated. In the latest episode of The Centrifuge Sessions, hear from Samuel Haile, Ph.D., Director of Cell Biology at Kite Pharma, on how we're working to deliver cell therapies that offer new hope for patients.Originally published by Gilead SciencesAbout Gilead SciencesGilead Sciences, Inc. is...

Read more

Agape ATP Corporation Secured Landmark Jet Fuel Supply Agreement with Swiss One Oil & Gas AG

April 3, 2025 9:05 AM

NASDAQ-listed AGAPE ATP Corporation ("ATPC") through its subsidiary ATPC Green Energy Sdn. Bhd. ("ATPC Green Energy"), has entered into two Sales and Purchase Agreements ("SPAs") with an aggregate value of approximately USD 24 billion with Swiss One Oil & Gas AG ("Swiss One").These SPAs build upon an earlier Initial Corporate Purchase Order ("ICPO") signed in February 2025, which laid the foundation for the procurement and supply of refined...

Read more

UniDoc Announces Debt Settlement and Renews Marketing Engagement

April 3, 2025 9:00 AM

UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF) ("UniDoc" or the "Company") announces that it intends to settle $93,240 (equivalent to approximately €60,000) in debt owed to a certain creditor of the Company by issuing approximately 266,400 common shares of the Company at a deemed price of $0.35 per share (the "Debt Settlement"). The creditor is a company controlled by a director of the Company.The Company intends to complete the debt...

Read more

Aptevo Therapeutics $2.1 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules

April 3, 2025 8:50 AM

Aptevo Therapeutics Inc. (Nasdaq:APVO) ("Aptevo" or the "Company"), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies, announced today that it has entered into definitive securities purchase agreements for the purchase and sale of 1,764,710 shares of the Company's common stock in a registered direct offering and warrants to...

Read more

March Monthly Update - Continued Growth and Important Progress

April 3, 2025 8:40 AM

iZafe Group (STO:IZAFE-B) - After an increase of billable Dosell units by 25% in January and an additional 9% in February, the number rose by another 12% in March. This is a clear indication that our strategy is working and that demand for our solution continues to grow.At the same time, it's important to emphasize that we are still in an early stage. Growth is occurring from relatively low levels, but the pace is exceptional. During the first...

Read more

Course of Gubra A/S' Annual General Meeting 2025

April 3, 2025 8:30 AM

Gubra (CPH:GUBRA)On Thursday, 3 April 2025 at 10:00 am (CEST), the annual general meeting of Gubra A/S (the "Company") was held at the Company's registered address Hørsholm Kongevej 11B, DK-2970 Hørsholm, with the following agenda:1. The board of directors' report on the Company's activities during the past financial year2. Presentation of the audited annual report for adoption3. Resolution on the appropriation of profit or payment of loss in...

Read more

CASI Pharmaceuticals Announces Receipt of An Updated Non-Binding Proposal to Acquire Entire China Business of the Company

April 3, 2025 8:00 AM

CASI Pharmaceuticals, Inc. (Nasdaq:CASI, "CASI"), a Cayman incorporated biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, announced that its special committee of the board of directors (the "Special Committee") has received an updated preliminary non-binding proposal letter (the "Proposal Letter"), dated April 2, 2025, from Dr. Wei-Wu He, Chairman of the board of directors...

Read more

Senzime Comments on US Market Tariffs

April 3, 2025 6:30 AM

Senzime (STO:SEZI)(OTCQX:SNZZF) - Uppsala, Sweden - Senzime comments on the April 2 announcement on imposed new US import tariffs effective April 9, 2025."We have different options on the table to mitigate the effects of the tariffs. One is utilizing our new US headquarters in St Louis for local market production. We also have a strong local supply chain that is not imposed to tariffs by this US Presidential order. And obviously, we have already...

Read more

Amphastar Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference

April 3, 2025 6:00 AM

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Dan Dischner, SVP of Corp. Communication, will be participating in an Analyst-Moderated fireside chat at the 24th Annual Needham Virtual Healthcare Conference on Wednesday, April 9th, 2025, at 1:30 pm ET. For access, visit Amphastar's Pharmaceuticals website at http://ir.amphastar.com. This webcast will be available for 30 days following the...

Read more